Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial
Journal of Gastroenterology · 2023
DOI: 10.1007/s00535-023-02027-1 ↗At a glance
Randomisierte kontrollierte Studie in Journal of Gastroenterology, 2023. Written by Min Wei and 9 co-authors. Institution: Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Major MEDLINE topics: Esophageal and Gastric Varices, Hypersplenism, Liver Cirrhosis, Gastrointestinal Hemorrhage. Cited 3 times so far (Crossref); 28 references.
Abstract (original language)
BACKGROUND: This study aimed to compare the efficacy of partial splenic embolization (PSE) combined with endoscopic therapy and endoscopic therapy alone in cirrhosis patients with acute variceal bleeding (AVB) and hypersplenism. METHODS: Cirrhosis patients with AVB who visited three hospitals from June 2016 to June 2022 were prospectively enrolled and randomly allocated to either the endoscopic therapy combined with PSE group (EP group) or the endoscopic intervention group (E group) in a 1:1 ratio. The primary endpoint of the study was re-bleeding of varices during follow-up, and the secondary endpoints were the recurrence of varices, death, and adverse events. RESULTS: One hundred and fourteen patients were prospectively included, of whom 110 completed the trial. The risk of variceal re-bleeding (19.3% vs. 40.4% (23/57), p = 0.013) and variceal recurrence (28.1% vs. 63.2%, p < 0.001) five years after treatment was significantly lower in the EP group than in the E group, and the EP treatment was the only significant independent risk factor affecting variceal re-bleeding and variceal recurrence in patients. The mortality rate was comparable between the EP and E groups. Peripheral blood counts and liver function all improved significantly in the EP group compared to the E group during the follow-up (p < 0.05). CONCLUSIONS: The rates of variceal re-bleeding and recurrence were significantly lower in cirrhosis patients with AVB and hypersplenism after combined endoscopic and PSE treatment compared to those who were provided endoscopic treatment only. The peripheral blood counts and liver function were also improved significantly in EP group (NCT02778425).
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Gastroenterology, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Department of Gastroenterology, Shandong Provincial Hospital, Jinan, Shandong, China.
- Department of Gastroenterology, The 960th Hospital of the Chinese People's Liberation Army, Jinan, Shandong, China.
- Department of Gastroenterology, Taian City Central Hospital, Taian, Shandong, China.
- Department of Gastroenterology, Central Hospital Affiliated of Shandong First Medical University, Jinan, Shandong, China.
- Department of Geriatric Medicine, Qilu Hospital of Shandong University, Jinan, Shandong, China. zhoutao@sdu.edu.cn.
ORCID profiles: Yanjing Gao
Cite
APA
Wei, M., Chen, Y., Wang, M., Li, J., Zeng, Y., Sun, X., Zhang, A., Liu, X., Zhou, T., & Gao, Y. (2023). Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial. Journal of Gastroenterology. https://doi.org/10.1007/s00535-023-02027-1
Vancouver
Wei M, Chen Y, Wang M, Li J, Zeng Y, Sun X, et al. Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial. Journal of Gastroenterology. 2023. doi:10.1007/s00535-023-02027-1
BibTeX
@article{Wei2023,
author = {Wei, Min and Chen, Yong and Wang, Minghui and Li, Jinhou and Zeng, Yunqing and Sun, Xin and Zhang, Anzhong and Liu, Xiaofeng and Zhou, Tao and Gao, Yanjing},
title = {Partial splenic embolization combined with endoscopic therapies and vasoconstrictive drugs reduces rebleeding in cirrhosis patients with acute variceal bleeding and hypersplenism: a multicenter randomized controlled trial},
journal = {Journal of Gastroenterology},
year = {2023},
doi = {10.1007/s00535-023-02027-1}
}
EUVIMED